Issue 9, 2011

Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold

Abstract

A novel and simplified synthetic scaffold based on pladienolide was designed using a consensus pharmacophore hypothesis. An initial target was synthesized and evaluated to examine the role of the 3-hydroxy group and the methyl groups present at positions 10, 16, 20, 22 in 1, on biological activity. We report the first totally synthetic analog of this macrolide that shows biological activity. Our novel synthetic strategy enables the rapid synthesis of other new analogs of pladienolide in order to develop selective anticancer lead compounds.

Graphical abstract: Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold

Supplementary files

Article information

Article type
Concise Article
Submitted
09 Feb 2011
Accepted
30 Jun 2011
First published
21 Jul 2011

Med. Chem. Commun., 2011,2, 904-908

Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold

M. K. Gundluru, A. Pourpak, X. Cui, S. W. Morris and T. R. Webb, Med. Chem. Commun., 2011, 2, 904 DOI: 10.1039/C1MD00040C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements